183 related articles for article (PubMed ID: 25147093)
1. Diphtheria toxin-based recombinant murine IL-2 fusion toxin for depleting murine regulatory T cells in vivo.
Wei M; Marino J; Trowell A; Zhang H; Stromp Peraino J; Rajasekera PV; Madsen JC; Sachs DH; Huang CA; Benichou G; Wang Z
Protein Eng Des Sel; 2014 Sep; 27(9):289-95. PubMed ID: 25147093
[TBL] [Abstract][Full Text] [Related]
2. Diphtheria toxin-based bivalent human IL-2 fusion toxin with improved efficacy for targeting human CD25(+) cells.
Peraino JS; Zhang H; Rajasekera PV; Wei M; Madsen JC; Sachs DH; Huang CA; Wang Z
J Immunol Methods; 2014 Mar; 405():57-66. PubMed ID: 24462799
[TBL] [Abstract][Full Text] [Related]
3. Development of a diphtheria toxin-based recombinant porcine IL-2 fusion toxin for depleting porcine CD25+ cells.
Peraino JS; Schenk M; Li G; Zhang H; Farkash EA; Sachs DH; Huang CA; Duran-Struuck R; Wang Z
J Immunol Methods; 2013 Dec; 398-399():33-43. PubMed ID: 24055128
[TBL] [Abstract][Full Text] [Related]
4. Ontak-like human IL-2 fusion toxin.
Wang Z; Zheng Q; Zhang H; Bronson RT; Madsen JC; Sachs DH; Huang CA; Wang Z
J Immunol Methods; 2017 Sep; 448():51-58. PubMed ID: 28551309
[TBL] [Abstract][Full Text] [Related]
5. Targeted therapy to the IL-2R using diphtheria toxin and caspase-3 fusion proteins modulates Treg and ameliorates inflammatory colitis.
Yarkoni S; Sagiv Y; Kaminitz A; Farkas DL; Askenasy N
Eur J Immunol; 2009 Oct; 39(10):2850-64. PubMed ID: 19735074
[TBL] [Abstract][Full Text] [Related]
6. A truncated diphtheria toxin based recombinant porcine CTLA-4 fusion toxin.
Peraino JS; Schenk M; Zhang H; Li G; Hermanrud CE; Neville DM; Sachs DH; Huang CA; Duran-Struuck R; Wang Z
J Immunol Methods; 2013 May; 391(1-2):103-11. PubMed ID: 23470981
[TBL] [Abstract][Full Text] [Related]
7. Reactivity of murine cytokine fusion toxin, diphtheria toxin390-murine interleukin-3 (DT390-mIL-3), with bone marrow progenitor cells.
Chan CH; Blazar BR; Greenfield L; Kreitman RJ; Vallera DA
Blood; 1996 Aug; 88(4):1445-56. PubMed ID: 8695865
[TBL] [Abstract][Full Text] [Related]
8. PTD-hFOXP3 protein acts as an immune regulator to convert human CD4(+)CD25(-) T cells to regulatory T-like cells.
Liu X; Xu X; Lin X; Tian Y; Ji B; Xia S; Xu S; Yin Q; Zhang M; Jiao Z; Wang S; Xu H; Shao Q
J Cell Biochem; 2012 Dec; 113(12):3797-809. PubMed ID: 22806628
[TBL] [Abstract][Full Text] [Related]
9. Depletion of CD4+CD25+ human regulatory T cells in vivo: kinetics of Treg depletion and alterations in immune functions in vivo and in vitro.
Mahnke K; Schönfeld K; Fondel S; Ring S; Karakhanova S; Wiedemeyer K; Bedke T; Johnson TS; Storn V; Schallenberg S; Enk AH
Int J Cancer; 2007 Jun; 120(12):2723-33. PubMed ID: 17315189
[TBL] [Abstract][Full Text] [Related]
10. Depletion of human regulatory T cells.
Hobeika AC; Morse MA; Osada T; Peplinski S; Lyerly HK; Clay TM
Methods Mol Biol; 2011; 707():219-31. PubMed ID: 21287338
[TBL] [Abstract][Full Text] [Related]
11. Depletion of Foxp3+ regulatory T cells increases severity of mechanical allodynia and significantly alters systemic cytokine levels following peripheral nerve injury.
Lees JG; Duffy SS; Perera CJ; Moalem-Taylor G
Cytokine; 2015 Feb; 71(2):207-14. PubMed ID: 25461400
[TBL] [Abstract][Full Text] [Related]
12. Stimulation of α7 nicotinic acetylcholine receptor by nicotine increases suppressive capacity of naturally occurring CD4+CD25+ regulatory T cells in mice in vitro.
Wang DW; Zhou RB; Yao YM; Zhu XM; Yin YM; Zhao GJ; Dong N; Sheng ZY
J Pharmacol Exp Ther; 2010 Dec; 335(3):553-61. PubMed ID: 20843956
[TBL] [Abstract][Full Text] [Related]
13. Diphtheria-toxin based anti-human CCR4 immunotoxin for targeting human CCR4(+) cells in vivo.
Wang Z; Wei M; Zhang H; Chen H; Germana S; Huang CA; Madsen JC; Sachs DH; Wang Z
Mol Oncol; 2015 Aug; 9(7):1458-70. PubMed ID: 25958791
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of anti-tumor immunity by high levels of Th1 and Th17 with a combination of dendritic cell fusion hybrids and regulatory T cell depletion in pancreatic cancer.
Yamamoto M; Kamigaki T; Yamashita K; Hori Y; Hasegawa H; Kuroda D; Moriyama H; Nagata M; Ku Y; Kuroda Y
Oncol Rep; 2009 Aug; 22(2):337-43. PubMed ID: 19578774
[TBL] [Abstract][Full Text] [Related]
15. Dendritic cells support homeostatic expansion of Foxp3+ regulatory T cells in Foxp3.LuciDTR mice.
Suffner J; Hochweller K; Kühnle MC; Li X; Kroczek RA; Garbi N; Hämmerling GJ
J Immunol; 2010 Feb; 184(4):1810-20. PubMed ID: 20083650
[TBL] [Abstract][Full Text] [Related]
16. IL-2 contributes to maintaining a balance between CD4+Foxp3+ regulatory T cells and effector CD4+ T cells required for immune control of blood-stage malaria infection.
Berretta F; St-Pierre J; Piccirillo CA; Stevenson MM
J Immunol; 2011 Apr; 186(8):4862-71. PubMed ID: 21389253
[TBL] [Abstract][Full Text] [Related]
17. IL-2 induces in vivo suppression by CD4(+)CD25(+)Foxp3(+) regulatory T cells.
Brandenburg S; Takahashi T; de la Rosa M; Janke M; Karsten G; Muzzulini T; Orinska Z; Bulfone-Paus S; Scheffold A
Eur J Immunol; 2008 Jun; 38(6):1643-53. PubMed ID: 18493984
[TBL] [Abstract][Full Text] [Related]
18. Selective depletion of Foxp3+ regulatory T cells improves effective therapeutic vaccination against established melanoma.
Klages K; Mayer CT; Lahl K; Loddenkemper C; Teng MW; Ngiow SF; Smyth MJ; Hamann A; Huehn J; Sparwasser T
Cancer Res; 2010 Oct; 70(20):7788-99. PubMed ID: 20924102
[TBL] [Abstract][Full Text] [Related]
19. Genetic assembly and selective toxicity of diphtheria-toxin-related polypeptide hormone fusion proteins.
Murphy JR; Bishai W; Williams D; Bacha P; Borowski M; Parker K; Boyd J; Waters C; Strom TB
Biochem Soc Symp; 1987; 53():9-23. PubMed ID: 2847744
[TBL] [Abstract][Full Text] [Related]
20. Effect of DAB(389)IL-2 immunotoxin on the course of experimental autoimmune encephalomyelitis in Lewis rats.
Phillips SM; Bhopale MK; Constantinescu CS; Ciric B; Hilliard B; Ventura E; Lavi E; Rostami A
J Neurol Sci; 2007 Dec; 263(1-2):59-69. PubMed ID: 17603081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
